Evidence map›Paper›PMID 39741938›Full record

Observational studyFrontiers in public health2024

Lactate dehydrogenase to albumin ratio (LAR) is a novel predictor of fatal outcome in patients with SFTS: an observational study.

Tao Meng, Wenqian Ding, Dongmei Lv, Chenxu Wang, Yuanhong Xu

Abstract readObservational Study
In one paragraph

Observational study in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tao Meng *Department of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Wenqian Ding *Department of Pediatrics, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Dongmei LvDepartment of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Chenxu WangDepartment of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Yuanhong XuDepartment of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Severe fever with thrombocytopenia syndrome (SFTS) is a serious infectious disease. This study explored the prognostic value of lactate dehydrogenase (LDH) to albumin (ALB) ratio (LAR) levels in fatal outcomes of the disease. Methods: Two-hundred and nine patients with SFTS were enrolled in this study. Based on the prognosis, patients were divided into survival and deceased groups. Laboratory metrics were compared by univariate Cox regression and multivariate Cox regression analyses. The prognostic risk factors for SFTS disease were discussed, and the receiver operator characteristic (ROC) curve and the Kaplan-Meier survival curve were plotted to analyze the predictive value of independent risk factors on disease prognosis. Results: A total of 209 patients with SFTS, including 152 in the survival group and 57 in the death group, were enrolled. The median age of 209 SFTS patients was 64 years. Three indicators, age, aspartate aminotransferase (AST), and LAR, were identified as predictors of mortality in patients with SFTS. The area under the ROC curve of LAR was the highest (0.835), followed by that of AST (0.794), and age (0.720). The Kaplan-Meier survival curve showed an increased case fatality rate, of >1.4691, in patients with LAR. Conclusion: Elevated LAR level on admission is an independent risk factor for fatal outcomes in patients with SFTS; this can help healthcare professionals identify patients with SFTS having a high risk of fatal outcomes.

Indexed as

L-Lactate DehydrogenaseAdultAgedAged, 80 and overAspartate AminotransferasesBiomarkersFemaleHumansKaplan-Meier EstimateMaleMiddle AgedPrognosisRisk FactorsROC CurveSerum AlbuminThrombocytopeniaAspartate AminotransferasesBiomarkersL-Lactate DehydrogenaseSerum Albuminalbuminlactate dehydrogenaseLARpredictorsevere fever and thrombocytopenia syndrome

Identifiers

PMID39741938
PMCPMC11685223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.